Editorial Staff

Valuing Life-Saving Drugs: What is the Price of Life and Who Decides?

/in , , , /by Editorial Staff
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Hubwonk host Joe Selvaggi talks with Pioneer Institute visiting fellow Dr. Bill Smith about Quality Adjusted Life Years (QALY) standards, and the ways in which so-called objective cost-containing strategies use expert opinion to determine the value of a life and thereby disadvantage the elderly, disabled, and those with less common vulnerabilities to disease.

Guest:

William S. Smith is Visiting Fellow in Life Sciences at Pioneer Institute. He has 25 years of experience in government and in corporate roles, including as vice president of public affairs and policy at Pfizer, and as a consultant to major pharmaceutical, biotechnology and medical device companies. He held senior staff positions for the Republican House leadership on Capitol Hill, the White House, and in the Massachusetts Governor’s office. He is affiliated as research fellow and managing director with the Center for the Study of Statesmanship at The Catholic University of America (CUA), where he earned his PhD.

Related research: Analysis: ICER Framework Ignores Patient Preferences, Innovation & Societal Benefits in Evaluating Cost-Effectiveness of New Cancer Treatments

Get new episodes of Hubwonk in your inbox!

Related Posts:

Contours of Content Curation: SCOTUS Hears Online Free Speech Cases

Cato Institute's Thomas Berry, talks about oral arguments at the Supreme Court in the NetChoice cases, exploring the First Amendment questions that affect both social media users and the platforms that curate their content.

Mortgage’s New Normal: Guide to Better Borrowing Amidst Higher Rates

Joe Selvaggi talks with mortgage expert, Trip Miller of Cambridge Savings Bank, about mortgage rates and trends and explores best practices for finding a mortgage structure that suits individual buyers’ needs.

Medicaid’s Massive Miasma: Taming Beacon Hill’s Burgeoning Budget Beast

Marc Joffe, a state policy analyst at the Cato Institute, talks about his research on Medicaid's cost and size. They explore how Massachusetts can control spending growth while protecting other priorities.

Baystate Budget Blues: Declining Revenue Causes Concern

Joe Selvaggi engages in a conversation with Pioneer Institute’s Eileen McAnneny, Senior Fellow for Economic Opportunity, to analyze the status of the 2024 budget. They compare actual revenue and spending with pre-July 1 estimates, investigating potential reasons for any surpluses or shortfalls. They also dive into policy implications for legislators as they approach fiscal 2025.

Smothering Gas Exports: President Sides with Environmentalists Over Environment

Dr. Benjamin Zycher, a senior fellow at the American Enterprise Institute, talks on the impact of President Biden's executive order to halt liquefied natural gas export approvals. He explores potential economic impacts, the response from trading partners, and the negligible effect on climate.

U.S. Manufacturing Health: Does the U.S. Need an Industrial Policy?

Scott Lincicome from the Cato Institute discusses the U.S. manufacturing industry, international trade, and industrial policy. He dispels the myth of manufacturing decline, highlighting sector evolution and productivity. The conversation moves to industrial policy, emphasizing the need for targeted protection and cautioning against broad subsidization due to potential inefficiencies.

Challenging Government Prerogatives: SCOTUS Reconsiders Deference to Executive Agencies

Joe Selvaggi engages in a conversation with legal scholar Ilya Shapiro from the Manhattan Institute regarding the Loper Bright Enterprises Supreme Court case that questions the Chevron Doctrine. This doctrine instructs judges to defer to government agencies in situations where laws are silent or unclear.

Harvard’s Sullied Halo: Journalists Teach Lesson on Plagiarism

Joe Selvaggi talks with investigative reporter Chris Brunet about his role investigating and exposing former Harvard President Claudine Gay’s academic plagiarism, a story that lead to her eventual resignation.

Drug Discount Distortions: How Middlemen Increase Costs and Reduce Access

Joe Selvaggi talks with Drs. Bill Smith and Robert Popovian about how the complex system of rebates from drug companies to insurance firms serve to increase costs and reduce access for patients.

Boston’s Building Bargain: Coaxing Commercial Conversions to Condos

Joe Selvaggi discusses the strategic goals of Boston's Downtown Office to Residential Conversion Pilot Program with Arthur Jemison, the head of BPDA planning. The aim is to transform underutilized offices in Downtown into vibrant places to live.